<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02298322</url>
  </required_header>
  <id_info>
    <org_study_id>ZA14-002</org_study_id>
    <nct_id>NCT02298322</nct_id>
  </id_info>
  <brief_title>Subcutaneous Fat Reduction in the Submental Area</brief_title>
  <official_title>Study to Evaluate Non-Invasive Subcutaneous Fat Reduction in the Submental Area Using Cryolipolysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zeltiq Aesthetics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zeltiq Aesthetics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to Evaluate Non-Invasive Subcutaneous Fat Reduction in the Submental Area using&#xD;
      Cryolipolysis.&#xD;
&#xD;
      Healthy adult men and women with submental skin fold thickness &gt; 1cm who desire reduction of&#xD;
      submental fat.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-invasive treatment for subcutaneous fat reduction in the submental area.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 11, 2014</start_date>
  <completion_date type="Actual">August 2, 2015</completion_date>
  <primary_completion_date type="Actual">August 2, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of CoolScupting in the Submental Area</measure>
    <time_frame>Time of enrollment through12 week post-final treatment follow-up</time_frame>
    <description>Safety of the Zeltiq CoolSculpting device will be assessed by measuring the incidence of device- and/or procedure-related adverse events. Adverse event reports are collected from the time of enrollment through the 12 week follow-up visit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Correct Identification of Pre-treatment Photographs</measure>
    <time_frame>12 week post-final-treatment</time_frame>
    <description>Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the treated areas. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the Fat Layer of the Treated Area as Measured by Ultrasound</measure>
    <time_frame>12 weeks post-final treatment</time_frame>
    <description>Change in the fat layer thickness will be calculated by comparison of pre-treatment and 16 week post-treatment ultrasound measurements taken in the area treated with the device. The Sponsor's standardized techniques for obtaining ultrasound imaging will be used. Results indicate the fat layer reduction in cm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Satisfaction With CoolScupting in the Submental Area</measure>
    <time_frame>12 weeks post-final treatment</time_frame>
    <description>Subject satisfaction as assessed by questionnaires administered at 12 weeks post-final treatment. The questionnaire will ask the subject about their treatment experience and the efficacy of the treatment.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Body Fat Disorder</condition>
  <arm_group>
    <arm_group_label>CoolSculpting Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention is the CoolSculpting System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CoolSculpting System</intervention_name>
    <arm_group_label>CoolSculpting Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female subjects &gt; 22 years of age and &lt; 65 years of age.&#xD;
&#xD;
          -  Submental skin fold thickness &gt; 1cm (measured by caliper).&#xD;
&#xD;
          -  No weight change exceeding 5% of body weight in the preceding month.&#xD;
&#xD;
          -  Agreement to maintain his/her weight (i.e., within 5%) by not making any major changes&#xD;
             in diet or exercise routine during the course of the study.&#xD;
&#xD;
          -  Subject has signed a written informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Skin laxity in the neck or chin area for which reduction in submental fat may, in the&#xD;
             opinion of the investigator, result in an unacceptable aesthetic result.&#xD;
&#xD;
          -  Prominent platysmal bands at rest which may interfere with assessment of submental fat&#xD;
&#xD;
          -  Evidence of any cause of enlargement in the submental area other than localized&#xD;
             subcutaneous fat, such as swollen lymph nodes or ptotic submandibular glands.&#xD;
&#xD;
          -  Significant enlargement on the anterior neck that may prevent the proper placement of&#xD;
             the applicator e.g. enlarged thyroid glands.&#xD;
&#xD;
          -  Treatment with dermal fillers, radiofrequency or laser procedures, or chemical peels&#xD;
             in the neck or chin area (below the mandible) within the past 6 months.&#xD;
&#xD;
          -  Botulinum toxin or other aesthetic drug injections within the neck or chin area (below&#xD;
             the mandible) within the past 6 months.&#xD;
&#xD;
          -  History of facial nerve paresis or paralysis (such as Bell's palsy).&#xD;
&#xD;
          -  History of a fat reduction procedure (e.g., liposuction, surgery, lipolytic agents,&#xD;
             etc.) or implant in or adjacent to the area of intended treatment.&#xD;
&#xD;
          -  History of prior neck surgery, or prior surgery in the area of intended treatment.&#xD;
&#xD;
          -  Current dental infection.&#xD;
&#xD;
          -  Known history of cryoglobulinemia, cold urticaria, or paroxysmal cold hemoglobinuria.&#xD;
&#xD;
          -  Known history of Raynaud's disease, or any known condition with a response to cold&#xD;
             exposure that limits blood flow to the skin.&#xD;
&#xD;
          -  History of bleeding disorder or is taking any medication that in the investigator's&#xD;
             opinion may increase the subject's risk of bruising.&#xD;
&#xD;
          -  Currently taking or has taken diet pills or weight control supplements within the past&#xD;
             month.&#xD;
&#xD;
          -  Any dermatological conditions, such as scars in the location of the treatment area&#xD;
             that may interfere with the treatment or evaluation.&#xD;
&#xD;
          -  Active implanted device such as a pacemaker, defibrillator, or drug delivery system.&#xD;
&#xD;
          -  Pregnant or intending to become pregnant in the next 6 months.&#xD;
&#xD;
          -  Lactating or has been lactating in the past 6 months.&#xD;
&#xD;
          -  Unable or unwilling to comply with the study requirements.&#xD;
&#xD;
          -  Currently enrolled in a clinical study of an unapproved investigational drug or&#xD;
             device.&#xD;
&#xD;
          -  Any other condition or laboratory value that would, in the professional opinion of the&#xD;
             investigator, potentially affect the subject's response or the integrity of the data&#xD;
             or would pose an unacceptable risk to the subject.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lori Brandt, BSN</last_name>
    <role>Study Director</role>
    <affiliation>Zeltiq Aesthetics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laser &amp; Skin Surgery Center of Northern California</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zel Skin &amp; Laser Specialists</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55424</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EpiCentre Skin and Laser Center</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>November 19, 2014</study_first_submitted>
  <study_first_submitted_qc>November 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2014</study_first_posted>
  <results_first_submitted>August 10, 2020</results_first_submitted>
  <results_first_submitted_qc>September 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 24, 2020</results_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>CoolSculpting Treatment</title>
          <description>Subjects treated with Coolsculpting for subcutaneous fat reduction in the submental area</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Subjects treated with CoolSculpting for subcutaneous fat reduction in the submental area</population>
      <group_list>
        <group group_id="B1">
          <title>CoolSculpting Treatment</title>
          <description>Subjects treated with CoolSculpting for fat reduction in the submittal area</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.3" lower_limit="25" upper_limit="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Safety of CoolScupting in the Submental Area</title>
        <description>Safety of the Zeltiq CoolSculpting device will be assessed by measuring the incidence of device- and/or procedure-related adverse events. Adverse event reports are collected from the time of enrollment through the 12 week follow-up visit.</description>
        <time_frame>Time of enrollment through12 week post-final treatment follow-up</time_frame>
        <population>As-treated population of 60 subjects who received CoolSculpting treatment for subcutaneous fat reduction in the submental area.</population>
        <group_list>
          <group group_id="O1">
            <title>CoolSculpting Treatment</title>
            <description>Subjects treated with CoolSculpting for subcutaneous fat reduction in the submental area</description>
          </group>
        </group_list>
        <measure>
          <title>Safety of CoolScupting in the Submental Area</title>
          <description>Safety of the Zeltiq CoolSculpting device will be assessed by measuring the incidence of device- and/or procedure-related adverse events. Adverse event reports are collected from the time of enrollment through the 12 week follow-up visit.</description>
          <population>As-treated population of 60 subjects who received CoolSculpting treatment for subcutaneous fat reduction in the submental area.</population>
          <units>incidence of device- and/or procedure AE</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Correct Identification of Pre-treatment Photographs</title>
        <description>Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the treated areas. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure.</description>
        <time_frame>12 week post-final-treatment</time_frame>
        <population>Subjects included in the analysis group (58) received full treatment; treatment was interrupted for 2 subjects not included in this population.</population>
        <group_list>
          <group group_id="O1">
            <title>CoolSculpting Treatment</title>
            <description>Per-protocol subjects treated with CoolSculpting for fat reduction in the submental area</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Correct Identification of Pre-treatment Photographs</title>
          <description>Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the treated areas. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure.</description>
          <population>Subjects included in the analysis group (58) received full treatment; treatment was interrupted for 2 subjects not included in this population.</population>
          <units>percentage of correcty identified photos</units>
          <param>Number</param>
          <units_analyzed>photo pairs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>photo pairs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>t-test, 1 sided</method>
            <param_type>sucess proportion</param_type>
            <param_value>91.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>86.2</ci_lower_limit>
            <ci_upper_limit>95.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Fat Layer of the Treated Area as Measured by Ultrasound</title>
        <description>Change in the fat layer thickness will be calculated by comparison of pre-treatment and 16 week post-treatment ultrasound measurements taken in the area treated with the device. The Sponsor's standardized techniques for obtaining ultrasound imaging will be used. Results indicate the fat layer reduction in cm.</description>
        <time_frame>12 weeks post-final treatment</time_frame>
        <population>Evaluable ultrasound images were available for 57 of the 59 subjects completing the 12 week follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>CoolSculpting Treatment</title>
            <description>Subjects with CoolSculpting treatment for subcutaneous fat reduction of the submental area</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Fat Layer of the Treated Area as Measured by Ultrasound</title>
          <description>Change in the fat layer thickness will be calculated by comparison of pre-treatment and 16 week post-treatment ultrasound measurements taken in the area treated with the device. The Sponsor's standardized techniques for obtaining ultrasound imaging will be used. Results indicate the fat layer reduction in cm.</description>
          <population>Evaluable ultrasound images were available for 57 of the 59 subjects completing the 12 week follow-up visit.</population>
          <units>cm fat layer reduction post-procedure</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.20" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Satisfaction With CoolScupting in the Submental Area</title>
        <description>Subject satisfaction as assessed by questionnaires administered at 12 weeks post-final treatment. The questionnaire will ask the subject about their treatment experience and the efficacy of the treatment.</description>
        <time_frame>12 weeks post-final treatment</time_frame>
        <population>As-treated population of subjects who received CoolSculpting for subcutaneous fat reduction of the submental area who completed a Subject Satisfaction Questionnaire at the 12-week final follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>CoolSculpting Treatment</title>
            <description>As-treated population of subjects who received CoolSculpting for subcutaneous fat reduction of the submental area who completed a Subject Satisfaction Questionnaire at the 12-week final follow-up visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Satisfaction With CoolScupting in the Submental Area</title>
          <description>Subject satisfaction as assessed by questionnaires administered at 12 weeks post-final treatment. The questionnaire will ask the subject about their treatment experience and the efficacy of the treatment.</description>
          <population>As-treated population of subjects who received CoolSculpting for subcutaneous fat reduction of the submental area who completed a Subject Satisfaction Questionnaire at the 12-week final follow-up visit.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visible/Very Visible Fat Reduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfied/VerySatisfied with CoolSculpting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Procedure was Very Comfortable/Comfortable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strongly Agree/Agree Procedure made more youthful</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strongly Agree/Agree chin looked more toned</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strongly Agree/Agree appearance has improved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Effect from procedure More Than Expected/Expected</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Would recommend procedure to a friend</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Feel less self-conscious about chin fat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected from enrollment through the 12-week final follow-up visit.</time_frame>
      <desc>Anticipated deaths = 0 participants Unanticipated deaths = 0 participants</desc>
      <group_list>
        <group group_id="E1">
          <title>CoolSculpting Treatment</title>
          <description>Subjects treated with Coolsculpting for subcutaneous fat reduction in the submental area</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Food poisoning</sub_title>
                <description>Food poisoning reported as moderate in severity. No relationship to CoolSculpting System or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Skin Cancer</sub_title>
                <description>Skin cancer on back, reported as severe. Not related to CoolSculpting System or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Food Poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Hives</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cold</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cold sore</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Back of throat fullness sensation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper respiratory infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Breast infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pinched nerve</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Broken finger</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Torn meniscus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Prolonged erythema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyper pigmentation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs</name_or_title>
      <organization>Zeltiq Aesthetics, Inc. an Allergan Affiliate</organization>
      <phone>(925) 621-7462</phone>
      <email>Kerrie.Jiang@allergan.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

